文献速递肝病

年龄、体重指数和2型糖尿病改变PNPLA3与非酒精性脂肪性肝病儿童和成人晚期纤维化的关系

Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-12-23

研究纳入1047名儿童和2057名成人,探讨年龄、体重指数和2型糖尿病对PNPLA3 G等位基因与组织学特征明确的非酒精性脂肪性肝病晚期纤维化关系的影响。PNPLA3 G等位基因与儿童和成人晚期纤维化显著相关,年龄、体重指数和2型糖尿病均修饰此关联。作者认为预防或逆转2型糖尿病和肥胖可能降低携带PNPLA3 G等位基因者的晚期纤维化风险。

要点

  • PNPLA3 G等位基因与儿童和成人晚期纤维化显著相关,儿童OR 1.55,成人OR 1.55。
  • 年龄增长显著增加各基因型晚期纤维化风险,CC、CG、GG的OR分别为1.019、1.024、1.03。
  • 体重指数30 kg/m2是PNPLA3 G等位基因对晚期纤维化风险呈指数效应的切点,2型糖尿病显著恶化该关系。

核心结论

  • 年龄、体重指数和2型糖尿病修饰PNPLA3 G等位基因相关的晚期纤维化风险。
  • 作者认为预防或逆转2型糖尿病和肥胖在携带PNPLA3 G等位基因者中可能降低非酒精性脂肪性肝病晚期纤维化风险。

研究设计与样本

  • 研究纳入1047名儿童和2057名成人,均有组织学特征明确的非酒精性脂肪性肝病。
  • DNA重复基因分型检测rs738409,主要结局为晚期纤维化(纤维化分期≥3)。
  • 控制相关协变量后行回归分析,采用加性模型评估PNPLA3 G等位基因效应(CC vs CG vs GG)。

主要发现

  • PNPLA3 G等位基因与晚期纤维化显著相关:儿童OR 1.55(95%CI 1.16-2.09),成人OR 1.55(95%CI 1.16-1.54)。
  • 年龄增长显著增加晚期纤维化风险:CC基因型OR 1.019(95%CI 1.013-1.026),CG基因型OR 1.024(95%CI 1.018-1.030),GG基因型OR 1.03(95%CI 1.023-1.037)。
  • 体重指数显著增加PNPLA3基因型与晚期纤维化的关系,体重指数30 kg/m2是PNPLA3 G等位基因对晚期纤维化风险呈指数效应的切点。
  • 2型糖尿病显著恶化PNPLA3 G等位基因与晚期纤维化的关系,儿童和成人交互作用P均<.01。

关键数值与推荐

  • 晚期纤维化定义为纤维化分期≥3。
  • PNPLA3 G等位基因与晚期纤维化关联:儿童OR 1.55(95%CI 1.16-2.09),成人OR 1.55(95%CI 1.16-1.54)。
  • 年龄对晚期纤维化风险OR:CC 1.019(95%CI 1.013-1.026),CG 1.024(95%CI 1.018-1.030),GG 1.03(95%CI 1.023-1.037)。
  • 体重指数30 kg/m2为PNPLA3 G等位基因对晚期纤维化风险呈指数效应的切点。
  • 2型糖尿病与PNPLA3 G等位基因交互作用P均<.01(儿童和成人)。

临床怎么用

  • 作者认为在携带PNPLA3 G等位基因者中预防或逆转2型糖尿病和肥胖可能降低非酒精性脂肪性肝病晚期纤维化风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: PNPLA3 G-allele is an important determinant of disease severity in nonalcoholic fatty liver disease (NAFLD). Here, we investigated the effect of age, body mass index (BMI), and type 2 diabetes mellitus (T2DM) on the relationship between PNPLA3 G-allele and advanced fibrosis in adults and children with histologically characterized NAFLD. METHODS: A total of 1047 children and 2057 adults were included. DNA was genotyped for rs738409 in duplicate. Primary outcome of interest was advanced fibrosis (fibrosis stage ≥3). Regression analyses were performed after controlling for relevant covariates. An additive model was used to assess the effect of PNPLA3 G-allele (CC vs CG vs GG). RESULTS: PNPLA3 G-allele was significantly associated with advanced fibrosis in children (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.16-2.09) and adults (OR, 1.55; 95% CI, 1.16-1.54). Across the cohort, older age significantly increased the risk for advanced fibrosis for PNPLA3 CC (OR, 1.019; 95% CI, 1.013-1.026), CG (OR, 1.024; 95% CI, 1.018-1.030), and GG (OR, 1.03; 95% CI, 1.023-1.037) genotypes. BMI significantly increased the relationship between PNPLA3 genotypes and advanced fibrosis in children and adults. A BMI of 30 kg/m2 was the cutoff beyond which PNPLA3 G-allele had exponential effect on the risk for advanced fibrosis in children and adults. T2DM significantly worsened the relationship between PNPLA3 G-allele and advanced fibrosis in children and adults (interaction P < .01 for both). CONCLUSIONS: Age, BMI, and T2DM modify the risk of advanced fibrosis associated with PNPLA3 G-allele. Preventing or reversing T2DM and obesity in persons carrying PNPLA3 G-allele may lower the risk for advanced fibrosis in NAFLD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Jarasvaraparn C, Vilar-Gomez E, Yates KP, et al. Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD. Clin Gastroenterol Hepatol. 2023. PMID: 38145725. doi:10.1016/j.cgh.2023.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。